Rhythm Biosciences Limited (RHY.AX)
Develops blood tests to detect colorectal cancer early
0.08+0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+35.0%
The outlook
RHY.AX is trading well below both its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. Analyst coverage appears thin or unavailable. The overall data leans bearish, with the stock showing weak near-term momentum and limited upside room within its recent yearly span.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range11% of the way from its 52-week low to high
Market cap
$28.7M
52-wk high
0.28
52-wk low
0.06
50-day avg
0.10
200-day avg
0.14
Trailing P/E
—